• Western blot analysis of various lysates using MRPL17 Rabbit polyclonal antibody (STJ118052) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 3min.

Anti-MRPL17 antibody (86-175) (STJ118052)

SKU:
STJ118052

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MRPL17 (86-175) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MRPL17
Gene ID: 63875
Uniprot ID: RM17_HUMAN
Immunogen Region: 86-175
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 86-175 of human MRPL17 (NP_071344.1).
Immunogen Sequence: IPKLFQVLAPRYKDQTGGYT RMLQIPNRSLDRAKMAVIEY KGNCLPPLPLPRRDSHLTLL NQLLQGLRQDLRQSQEASNH SSHTAQTPGI
Tissue Specificity Detected in adrenal gland, mammary gland and adipose tissue.
Protein Name Large Ribosomal Subunit Protein Bl17m
39s Ribosomal Protein L17 - Mitochondrial
L17mt
Mrp-L17
Lyst-Interacting Protein 2
Database Links Reactome: R-HSA-5368286
Reactome: R-HSA-5389840
Reactome: R-HSA-5419276
Cellular Localisation Mitochondrion
Alternative Antibody Names Anti-Large Ribosomal Subunit Protein Bl17m antibody
Anti-39s Ribosomal Protein L17 - Mitochondrial antibody
Anti-L17mt antibody
Anti-Mrp-L17 antibody
Anti-Lyst-Interacting Protein 2 antibody
Anti-MRPL17 antibody
Anti-LIP2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance